Oral Mucosal Disease Due to Graft-versus-host Disease
1 clinical trials · Condition
◉ Watch Oral Mucosal Disease Due to Graft-versus-host Disease
| Record | Firm | Date |
|---|---|---|
| An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease (NCT02123966) | Dana-Farber Cancer Institute | 2014-07-01 |
Track Oral Mucosal Disease Due to Graft-versus-host Disease automatically
Every clearance here is in the API, with alerts when new ones post.